Communiqué de presse : Sanofi et Biovac pionniers de la production de vaccins contre la polio en Afrique Sanofi et Biovac pionniers de la...
Sanofi: Information concerning the total number of voting rights and shares – May 2024 Information concerning the total number of voting...
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed...
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan Sanofi launches 2024 global Employee Stock Purchase Plan Paris, May...
Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO Le...
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation Update on FDA priority...
Communiqué de presse : Sanofi finalise l’acquisition d’Inhibrx, Inc. Sanofi finalise l’acquisition d’Inhibrx, Inc. Paris, le 30 mai 2024...
Communiqué de presse : La FDA accorde un examen prioritaire au Sarclisa pour le traitement des patients atteints d’un myélome multiple...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.